A Phase 2 Study of AZD6244 in Multiple Myeloma.
Phase of Trial: Phase II
Latest Information Update: 07 Oct 2015
At a glance
- Drugs Selumetinib (Primary)
- Indications Multiple myeloma
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 07 Oct 2015 Results published in the Clinical cancer research: an official journal of the American Association for Cancer Research.
- 22 Dec 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.